| Product NDC: | 0591-2886 |
| Proprietary Name: | Verapamil Hydrochloride |
| Non Proprietary Name: | verapamil hydrochloride |
| Active Ingredient(s): | 360 mg/1 & nbsp; verapamil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE PELLETS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0591-2886 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019614 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19900529 |
| Package NDC: | 0591-2886-01 |
| Package Description: | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2886-01) |
| NDC Code | 0591-2886-01 |
| Proprietary Name | Verapamil Hydrochloride |
| Package Description | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2886-01) |
| Product NDC | 0591-2886 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | verapamil hydrochloride |
| Dosage Form Name | CAPSULE, DELAYED RELEASE PELLETS |
| Route Name | ORAL |
| Start Marketing Date | 19900529 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Strength Number | 360 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |